The multi-stakeholder project “Reasonable agreements between patient advocates and pharmaceutical companies” aims to make legal agreements between both parties easier and more acceptable while providing adequate protection and rules for both sides. To do so, it has developed these guiding principles, which should provide the guiding baseline for the development of contracts and contract templates as well as a toolbox for patient advocates and companies.
PFMD Executive Director
/ / /
Communications Manager at Myeloma Patients Europe (MPE)